Covered recipient · General Payments record
DREW EDWARD MURRAY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2024
$778.01
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $586.71 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $209.60 | 14 |
| Corium, Inc. | $181.60 | 11 |
| Neuronetics, Inc. | $51.13 | 2 |
| Otsuka America Pharmaceutical, Inc. | $33.27 | 2 |
| Alkermes, Inc. | $22.42 | 1 |
| Brainsway USA INC | $20.06 | 1 |
| Braeburn Inc. | $19.93 | 1 |
| Noven Therapeutics, LLC | $18.23 | 1 |
| Indivior Inc. | $15.48 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.73 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085981 | CMS |
| ABBVIE INC. | $9.14 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085983 | CMS |
| ABBVIE INC. | $16.24 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085985 | CMS |
| ABBVIE INC. | $26.05 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085987 | CMS |
| ABBVIE INC. | $12.30 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085989 | CMS |
| ABBVIE INC. | $8.95 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085991 | CMS |
| ABBVIE INC. | $14.36 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085993 | CMS |
| ABBVIE INC. | $18.27 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085995 | CMS |
| ABBVIE INC. | $17.32 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085997 | CMS |
| ABBVIE INC. | $25.08 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105085999 | CMS |
| ABBVIE INC. | $7.38 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105086001 | CMS |
| ABBVIE INC. | $22.11 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105086003 | CMS |
| ABBVIE INC. | $13.34 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105086005 | CMS |
| ABBVIE INC. | $5.33 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105086007 | CMS |
| Alkermes, Inc. | $22.42 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120560276 | CMS |
| Braeburn Inc. | $19.93 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125600825 | CMS |
| Brainsway USA INC | $20.06 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128483451 | CMS |
| Corium, LLC | $7.95 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100126716 | CMS |
| Corium, LLC | $10.25 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100122492 | CMS |
| Corium, LLC | $10.30 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100122398 | CMS |
| Corium, LLC | $14.05 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100162401 | CMS |
| Corium, LLC | $26.73 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100195314 | CMS |
| Corium, LLC | $19.11 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100100766 | CMS |
| Corium, LLC | $18.35 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100173022 | CMS |
| Corium, LLC | $24.63 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100190681 | CMS |
| Corium, LLC | $19.88 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100177368 | CMS |
| Corium, LLC | $13.68 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100161633 | CMS |
| Corium, LLC | $16.67 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100219575 | CMS |
| Indivior Inc. | $15.48 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144534115 | CMS |
| Neuronetics, Inc. | $13.27 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073310268 | CMS |
| Neuronetics, Inc. | $37.86 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073312278 | CMS |
| Noven Therapeutics, LLC | $18.23 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084820209 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.20 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118947622 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.07 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118947624 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.99 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147878869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.